首页> 外文期刊>Cardiovascular drugs and therapy >Antihypertensive response to thiazide diuretic or angiotensin receptor blocker in elderly hypertensives is not influenced by pretreatment plasma renin activity.
【24h】

Antihypertensive response to thiazide diuretic or angiotensin receptor blocker in elderly hypertensives is not influenced by pretreatment plasma renin activity.

机译:老年高血压患者对噻嗪类利尿剂或血管紧张素受体阻滞剂的降压反应不受血浆血浆肾素活性的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Renin profiling has been proposed as a method to guide antihypertensive drug selection. This prespecified post-hoc analysis examined the influence of baseline plasma renin activity (PRA) on blood pressure (BP) responses.A 16-week, randomized, double-blind, prompted-titration trial evaluated initial valsartan (V)/hydrochlorothiazide (HCTZ) combination therapy versus initial HCTZ or V monotherapy in individuals aged ≥ 70 years with systolic hypertension. Sitting PRA was measured at baseline, Week 4, and Week 16. Subjects were stratified into 2 groups for analysis: low renin (baseline PRA < 0.65 ng/mL/h) or normal-high renin (baseline PRA ≥ 0.65 ng/mL/h).PRA data were available in 322/384 subjects: 178 had low PRA and 144 had normal-high PRA. At Week 4, V/HCTZ was more effective than HCTZ or V at reducing mean sitting systolic BP (MSSBP), independent of baseline PRA, with reductions of -16.9, -12.6, and -9.5 mmHg, respectively, in low-renin subjects and -19.4, -11.5, and -8.6 mmHg in normal-high renin subjects. Baseline PRA was similar in responders (subjects not uptitrated at Week 4) and nonresponders (subjects uptitrated at Week 4). In responders, the reactive rise in PRA at Week 4 was related to change in MSSBP, with the greatest increases in PRA observed in the V/HCTZ group. Higher baseline PRA was associated with a greater reactive rise in PRA.Baseline PRA is not a useful guide to the BP responses of initial combination V/HCTZ in elderly individuals with systolic hypertension.
机译:肾素分析已被提出作为指导抗高血压药物选择的方法。这项预先设定的事后分析检查了基线血浆肾素活性(PRA)对血压(BP)反应的影响。一项为期16周的随机双盲提示滴定试验评估了初始缬沙坦(V)/氢氯噻嗪(HCTZ) )对于年龄≥70岁的收缩期高血压患者,联合治疗与最初的HCTZ或V单药治疗。坐位PRA在基线,第4周和第16周进行测量。将受试者分为两组进行分析:低肾素(基线PRA <0.65 ng / mL / h)或正常高肾素(基线PRA≥0.65 ng / mL / h)。在322/384名受试者中可获得PRA数据:178名PRA低而144名正常PRA高。在第4周,V / HCTZ在降低平均坐位收缩压(MSSBP)(独立于基线PRA)方面比HCTZ或V更有效,在低肾素受试者中分别降低-16.9,-12.6和-9.5 mmHg在正常高肾素受试者中为-19.4,-11.5和-8.6 mmHg。应答者(受试者在第4周未升高)和未应答者(受试者在第4周升高)的基线PRA相似。在应答者中,第4周PRA的反应性升高与MSSBP的变化有关,在V / HCTZ组中PRA的增加最大。较高的基线PRA与较高的PRA反应性升高相关。基线PRA不能有效指导老年收缩期高血压患者初始联合V / HCTZ的BP反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号